White label ELPA - ClinicalTrials.eu

Study of RVU120 for Patients with Advanced Solid Tumors After Standard Treatments Have Failed

Not recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson’s Disease

Not recruiting

4 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Prasinezumab
Study on Improving Treatment for Sickle Cell Disease Patients Using Hydroxycarbamide

Not recruiting

3 1 1 1
Investigated diseases:
- Sickle cell disease
Investigated drugs:
- Hydroxycarbamide
Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

Not recruiting

3 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- Leuprorelin Acetate
- Enzalutamide
+4
Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

Not recruiting

2 1
Investigated drugs:
- Cannabis Sativa Flower
Study of Teclistamab with Daratumumab or Lenalidomide for Elderly Patients with Newly Diagnosed Multiple Myeloma

Not recruiting

2 1 1 1
Investigated drugs:
Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

Not recruiting

3 1 1
Investigated diseases:
- Immune thrombocytopenia
Investigated drugs:
- Efgartigimod Alfa
Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Not recruiting

3 1 1
Investigated diseases:
- Lupus nephritis
Investigated drugs:
+3
Study on Insulin Aspart, Salbutamol, and Glucose for Treating Acute Hyperkalemia in Emergency Department Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Hyperkalaemia
Investigated drugs:
Study on Venetoclax, Azacitidine, and Cusatuzumab for Newly Diagnosed Acute Myeloid Leukemia Patients Not Suitable for Intensive Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies